Nucleus Software Exports Limited Reports Q1 FY27 Results: Consolidated Net Profit Recorded at ₹23.87 Crore

Nucleus Software Exports Limited, a prominent provider of lending and transaction banking software solutions, has released its unaudited consolidated and standalone financial results for the first quarter ended June 30, 2026 (Q1 FY27). The company recorded stable operating revenue alongside net exceptional gains during the quarter.

Consolidated Financial Highlights

All figures in ₹ Lakhs unless explicitly stated otherwise.

For Q1 FY27, Nucleus Software Exports reported a consolidated Net Profit After Tax of ₹23.87 crore (₹2,387 lakhs), compared to ₹35.20 crore (₹3,520 lakhs) in Q1 FY26 and ₹34.55 crore (₹3,455 lakhs) in Q4 FY26.

Total consolidated income for the quarter stood at ₹228.26 crore (₹22,826 lakhs), compared to ₹235.68 crore in Q1 FY26 and ₹239.69 crore in Q4 FY26.

Revenue from Operations: Income from software products and services reached ₹210.43 crore (₹21,043 lakhs) for Q1 FY27, compared to ₹217.72 crore in Q1 FY26 and ₹224.77 crore in Q4 FY26.

Other Income: Reached ₹17.83 crore (₹1,783 lakhs), vs. ₹17.96 crore in Q1 FY26 and ₹14.92 crore in Q4 FY26.

Total Expenses: Stood at ₹207.98 crore (₹20,798 lakhs) in Q1 FY27 compared to ₹187.38 crore in Q1 FY26. Employee benefits expense represented the largest cost component at ₹157.18 crore.

Exceptional Items: The company recorded a net exceptional credit/gain of ₹9.82 crore (₹982 lakhs) during Q1 FY27, compared to an exceptional expense of ₹3.10 crore (₹310 lakhs) in Q4 FY26.

Profit Before Tax (PBT): Came in at ₹30.10 crore (₹3,010 lakhs) for Q1 FY27, compared to ₹48.30 crore in Q1 FY26 and ₹41.51 crore in Q4 FY26.

Total Comprehensive Income: Stood at ₹23.79 crore (₹2,379 lakhs) for Q1 FY27 against ₹39.83 crore in Q1 FY26.

Consolidated Geographical Segment Revenue

India remains the largest single market for Nucleus Software, contributing more than half of overall revenue:

India: ₹118.06 crore (vs. ₹126.70 crore in Q1 FY26)

Middle East: ₹25.48 crore (vs. ₹23.22 crore in Q1 FY26)

South East Asia: ₹22.81 crore (vs. ₹26.18 crore in Q1 FY26)

Others: ₹17.68 crore (vs. ₹15.91 crore in Q1 FY26)

Europe: ₹11.47 crore (vs. ₹10.73 crore in Q1 FY26)

Far East: ₹8.84 crore (vs. ₹6.99 crore in Q1 FY26)

Australia: ₹4.06 crore (vs. ₹5.85 crore in Q1 FY26)

Africa: ₹2.03 crore (vs. ₹2.14 crore in Q1 FY26)

Standalone Performance Summary

All figures in ₹ Lakhs unless explicitly stated otherwise.

On a standalone basis, Nucleus Software Exports reported:

Revenue from Operations: Stood at ₹193.69 crore (₹19,369 lakhs) in Q1 FY27, compared to ₹200.80 crore in Q1 FY26.

Total Income: Reached ₹211.43 crore (₹21,143 lakhs), compared to ₹225.08 crore in Q1 FY26.

Total Expenses: Came in at ₹192.50 crore (₹19,250 lakhs), driven by employee benefit expenses of ₹137.91 crore.

Profit Before Tax (PBT): Reported at ₹28.75 crore (₹2,875 lakhs) for Q1 FY27 (including ₹9.82 crore exceptional gain), compared to ₹52.54 crore in Q1 FY26.

Net Profit After Tax (PAT): Reached ₹22.95 crore (₹2,295 lakhs) for Q1 FY27, compared to ₹39.59 crore in Q1 FY26.

Total Comprehensive Income: Stood at ₹23.27 crore (₹2,327 lakhs) for Q1 FY27.

Earnings Per Share & Capital Metrics

Consolidated EPS: Basic and diluted Earnings Per Share for Q1 FY27 stood at ₹9.07 per share (face value ₹10.00 each), compared to ₹13.37 per share in Q1 FY26 and ₹13.12 per share in Q4 FY26.

Standalone EPS: Basic and diluted EPS came in at ₹8.72 per share for Q1 FY27, compared to ₹15.04 per share in Q1 FY26.

Paid-Up Equity Share Capital: Remained unchanged at ₹26.33 crore (₹2,633 lakhs) with a face value of ₹10.00 per share.

Shares of Nucleus Software Exports Limited was last trading in BSE at Rs. 736.20 as compared to the previous close of Rs. 740.05. The total number of shares traded during the day was 3183 in over 347 trades.

The stock hit an intraday high of Rs. 766.10 and intraday low of 731.90. The net turnover during the day was Rs. 2391250.00.

Source : Equity Bulls

Keywords

NucleusSoftwareExports INE096B01018 Q1FY27 Q1FY2027 ResultUpdate